Scientific References - Women's Health – Theralogix
Order online or call toll-free (800) 449-4447
  • Track Your Shipping
  • Cart
Track Your Shipping Login to Your Account Cart

Women's Health Scientific References

Fertility | Women's Health | Urology | Rheumatology | General Health


LATEST RESEARCH UPDATE: A recently published study evaluated the effect of diet, diet + myo-inositol (MI), or diet + MI + D-chiro-inositol (DCI) on clinical and body composition outcomes among overweight/obese women with Polycystic Ovary Syndrome (PCOS). Fourty-three women who were not on hormone therapy or taking any medications or over-the-counter products and did not have concurrent medical disease, were selected for this study. Weight loss was significant in all three groups after six months and was highest in the diet + MI + DCI group. This combination (diet + MI + DCI) was also the only group in which 100% of women experienced restoration of menstrual regularity. These results suggest that the combination of MI + DCI in a physiological plasma ratio of 40:1 is more effective than MI alone for menstrual cycle regulation among women with PCOS. For more information, check out the article abstract.


Cervical Health

Folate/Folic Acid
Green Tea
Vitamin A
Vitamin B12
Vitamin C
Vitamin D
Vitamin E



Omega-3 Fish Oil (DHA)

(2017/12) The effect of fish oil supplementation on maternal and neonatal outcomes: a triple-blind, randomized controlled trial.

(2016/03) Effects of omega-3 fatty acids in prevention of early preterm delivery: a systematic review and meta-analysis of randomized studies.

(2016/01) Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials.

(2015/08) The Effect of Omega-3 Docosahexaenoic Acid Supplementation on Gestational Length: Randomized Trial of Supplementation Compared to Nutrition Education for Increasing n-3 Intake from Foods.

(2012/06) Determinants of DHA levels in early infancy: differential effects of breast milk and direct fish oil supplementation.

(2011/07) Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age.

(2011/07) High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes.

(2010/12) Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants

(2010/12) Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development

(2010/08) Compartmental analyses of 2H5-alpha-linolenic acid and C-U-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n-3 in newborn term infants

(2010/02) The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid.

(2005/10) Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants

(2005/08) Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life

(2004/03) Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes

Vitamin D

(2018/09) Maternal Supplementation of Vitamin D during Lactation to Support Infant Vitamin D Needs: A Systematic Review.

(2018/01) A Longitudinal Study of 25-Hydroxy Vitamin D and Parathyroid Hormone Status throughout Pregnancy and Exclusive Lactation in New Zealand Mothers and Their Infants at 45° S.

(2016/01) Vitamin D content in human breast milk: a 9-mo follow-up study.

(2015/08) Maternal vitamin D₃ supplementation at 50 μg/d protects against low serum 25-hydroxyvitamin D in infants at 8 wk of age: a randomized controlled trial of 3 doses of vitamin D beginning in gestation and continued in lactation.

(2015/10) Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial.

(2014/09) Impact of vitamin D supplementation during lactation on vitamin D status and body composition of mother-infant pairs: a MAVID randomized controlled trial.

(2010/07) Circulating 25-hydroxyvitamin d levels in fully breastfed infants on oral vitamin d supplementation.

(2010/01) Use of supplemental vitamin d among infants breastfed for prolonged periods.

(2009/04) Vitamin D requirements in the first year of life

(2009/01) Effect of combined maternal and infant vitamin D supplementation on vitamin D status of exclusively breastfed infants.

(2008/11) Prevention of rickets and vitamin D deficiency in infants, children, and adolescents

(2007/06) Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women.

(2006/07) High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study.

(2006/04) The effect of high-dose vitamin D supplementation on serum vitamin D levels and milk calcium concentration in lactating women and their infants

(2004/12) Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant.




(2016/06) Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.

(2016/06) Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints.

(2015/04) Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review.

(2013/12) Phytoestrogens for menopausal vasomotor symptoms.

(2012/07) Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.

(2011/07) Soy extracts versus hormone therapy for reduction of menopausal hot flushes: indirect comparison.

(2011/05) The effect of soy-derived isoflavones over hot flushes, menopausal symptoms and mood in climacteric women with increased body mass index.

(2011/02) Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women.

(2010/11) The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial.

(2009/05) Various doses of soy isoflavones do not modify mammographic density in postmenopausal women.

(2009/03) Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.

(2008/07) Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones.

(2007/11) Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.

(2007/10) Phytoestrogens for vasomotor menopausal symptoms.

(2007/07) Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.

(2006/10) Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis.

(2006/09) Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies.

(2003/03) Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency.

(2002/03) Benefits of soy isoflavone therapeutic regimen on menopausal symptoms.

Vitamin D


Hormonal and Metabolic Health


(2019/03) Effects of three treatment modalities (diet, myoinositol or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome.

(2019/01) Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials.

(2019/01) Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial.

(2018/07) The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.

(2018/02) Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials.

(2017/11) Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials.

(2017/08) Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial.

(2017/06) Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols.

(2017/05) Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study.

(2017/01)Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).

(2016/10) Inositol Treatment and ART Outcomes in Women with PCOS

(2016/08)Myo-Inositol in the Treatment of Teenagers Affected by PCOS.

(2016/08) Prospective Randomized Study on the Influence of Myoinositol in PCOS Women Undergoing IVF in the Improvement of Oocyte Quality, Fertilization Rate, and Embryo Quality.

(2016/07) A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women.

(2015/12) Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.

(2015/08) Inositol versus Metformin administration in polycystic ovary syndrome patients: a case–control study

(2015/07) Reflections on inositol(s) for PCOS therapy: steps toward success.

(2015/02) Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance

(2014/10) The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.

(2014/05) Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome.

(2014/03) Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.

(2013/12) The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.

(2013/04) Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.

(2013/02) The combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.

(2012/05) The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.

(2012/02) Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition.

(2011/05) Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial.

(2011/04) Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.

(2010/04) Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.

(2009/08) Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.

(2009/05) Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.

(2009/03) Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.

(2007/09) Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.

Omega-3 Fish Oil
Vitamin D

(2019/01) A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.

(2018/04) The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

(2017/12) The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.

(2017/11) Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.

(2017/08) Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.

(2017/03) The Effect of Vitamin D Supplementation on the Androgenic Profile in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials.

(2017/02) Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.

(2015/10) Vitamin D Supplementation Decreases TGF-?1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial

(2014/06) High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial.



Calcium and Vitamin D
Coenzyme Q10
Folate/Folic Acid

(2019/01) Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.

(2018/09) Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.

(2018/03) Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.

(2018/02) The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-analysis of randomized controlled trials.

(2017/06) The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial.

(2016/10) Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.

(2015/12) Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.

(2015/10) Relationship Between Myo-Inositol Supplementary and Gestational Diabetes Mellitus: A Meta-Analysis.

(2015/08) Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.

(2013/07) Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.

(2013/04) Myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.

(2012/06) Myo-inositol may prevent gestational diabetes in PCOS women.

(2011/08) The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.


(2018/07) Iodine status during pregnancy and lactation: a pilot study in the Netherlands.

(2016/09) Consequences of iodine deficiency and excess in pregnant women: an overview of current knowns and unknowns.

(2013/11) Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trials.

(2011/12) Iodine nutrition in pregnancy and lactation.

(2011/09) Dietary iodine in pregnancy and postpartum.

(2011/04) Effect of iodine supplementation during pregnancy on infant neurodevelopment at 1 year of age.

(2010/11) The relationship of radiocontrast, iodine, and seafood allergies: a medical myth exposed.

(2010/06) Some Subgroups of Reproductive Age Women in the United States May Be at Risk for Iodine Deficiency

(2009/09) Effect of iodine prophylaxis during pregnancy on neurocognitive development of children during the first two years of life.

(2009/05) Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation.

(2009/02) Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a review

(2007/12) Iodine deficiency and brain development in the first half of pregnancy

(2007/12) The prevalence of iodine deficiency in women of reproductive age in the United States of America

(2007/09) The adverse effects of mild-to-moderate iodine deficiency during pregnancy and childhood: a review

(2006/10) Iodine supplementation for pregnancy and lactation-United States and Canada: recommendations of the American Thyroid Association

Omega-3 Fish Oil (DHA)

(2017/03) The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes.

(2016/10) Prenatal supplementation with DHA improves attention at 5 y of age: a randomized controlled trial.

(2016/09) The effect of prenatal docosahexaenoic acid supplementation on infant outcomes in African American women living in low-income environments: A randomized, controlled trial.

(2015/11) Effects of omega-3 fatty acids in prevention of early preterm delivery: a systematic review and meta-analysis of randomized studies.

(2013/04) DHA supplementation and pregnancy outcomes.

(2012/03) Omega-3 fatty acids and pregnancy: current implications for practice.

(2012/01) Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial.

(2011/08) Prenatal Docosahexaenoic Acid Supplementation and Infant Morbidity: Randomized Controlled Trial.

(2011/08) Evidence regarding an effect of marine n-3 fatty acids on preterm birth: a systematic review and meta-analysis.

(2011/08) Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review.

(2011/07) The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review.

(2011/06) Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial.

(2011/04) Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohort.

(2010/10) Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial

(2010/10) Effects of n-3 Long-Chain Polyunsaturated Fatty Acid Supplementation during Pregnancy and/or Lactation on Neurodevelopment and Visual Function in Children: A Systematic Review of Randomized Controlled Trials.

(2009/12) Atopy Risk in Infants and Children in Relation to Early Exposure to Fish, Oily Fish, or Long-Chain Omega-3 Fatty Acids: A Systematic Review

(2008/01) Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial

(2007/12) The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial

(2007/08) Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil

(2007/08) Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials

(2007/06) Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy?

(2007/06) Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo

(2003/12) Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial.

(2003/01) Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age

Vitamin B6
Vitamin D

(2018/01) Maternal Vitamin D Status and Risk of Gestational Diabetes: a Meta-Analysis.

(2018/01) Maternal early pregnancy vitamin D status in relation to low birth weight and small-for-gestational-age offspring.

(2017/11) Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials.

(2017/10) Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheeze in early childhood: A combined analysis of two randomized controlled trials.

(2017/09) Meta-analysis of the effect of the maternal vitamin D level on the risk of spontaneous pregnancy loss.

(2017/07) Maternal 25(OH)D concentrations ≥40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center.

(2015/10) Vitamin D status is inversely associated with anemia and serum erythropoietin during pregnancy.

(2015/01) Typical Prenatal Vitamin D Supplement Intake Does Not Prevent Decrease of Plasma 25-Hydroxyvitamin D at Birth

(2014/12) Dietary Fat Increases Vitamin D-3 Absorption.

(2014/07) Association Between Sex Steroids, Ovarian Reserve, and Vitamin D Levels in Healthy Nonobese Women

(2013/07) Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis.

(2013/03) Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies.

(2013/02) A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina.

(2012/09) Vitamin D deficiency in pregnancy and gestational diabetes mellitus.

(2012/08) Plasma 25-hydroxyvitamin D during pregnancy and small-for-gestational age in black and white infants.

(2012/07) Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort study in healthy Danish women.

(2012/05) Association of low serum 25-Hydroxyvitamin D levels in pregnancy with glucose homeostasis and obstetric and newborn outcomes.

(2012/04) Maternal vitamin D status and delivery by cesarean.

(2012/03) Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development.

(2012/03) Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia.

(2012/02) Vitamin D supplementation for women during pregnancy.

(2012/01) Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring.

(2011/12) Maternal vitamin D, folate, and polyunsaturated fatty acid status and bacterial vaginosis during pregnancy.

(2011/12) Vitamin D status during pregnancy: maternal, fetal, and postnatal outcomes.

(2011/10) Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness.

(2011/09) Systematic review of first-trimester vitamin D normative levels and outcomes of pregnancy.

(2011/06) Maternal vitamin D and fetal growth in early-onset severe preeclampsia.

(2011/06) Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis.

(2011/01) Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma.

(2011/01) Vitamin D deficiency and insufficiency is common during pregnancy.

(2011/01) Pregnancy-specific association of vitamin D deficiency and bacterial vaginosis.

(2010/12) Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia.

(2010/12) Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia

(2010/11) A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia

(2010/10) First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.

(2010/05) Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States.

(2010/05) Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women

(2010/01) Low maternal vitamin D status and fetal bone development: cohort study.

(2009/09) Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study.

(2009/06) Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy

(2009/05) Vitamin D deficiency and supplementation during pregnancy

(2009/04) Vitamin D intake during pregnancy: association with maternal characteristics and infant birth weight

(2009/03) Association between Vitamin D Deficiency and Primary Cesarean Section

(2008/03) Maternal Plasma 25-Hydroxyvitamin D Concentrations and the Risk for Gestational Diabetes Mellitus

(2007/02) High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates

(2006/01) Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study.


Urinary Tract Health


(2019/05) Recurrent Uncomplicated Urinary Tract Infections In Women: AUA/CUA/SUFU Guideline.

(2018/10) Cranberry Standardized Capsules May Prevent Recurrences of Urinary Tract Infections in Children.

(2017/12) Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review and Meta-Analysis.

(2017/09) Can Cranberries Contribute to Reduce the Incidence of Urinary Tract Infections? A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Clinical Trials.

(2016/11) Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes: A Randomized Clinical Trial.

(2016/09) Effect of oral cranberry extract (standardized proanthocyanidin-A) in patients with recurrent UTI by pathogenic E. coli: a randomized placebo-controlled clinical research study.

(2016/06) Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection.

(2015/12) Cranberry Products for the Prophylaxis of Urinary Tract Infections in Pediatric Patients.

(2015/08) Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial.

(2015/01) Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study.

(2014/01) Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons: a double-blind randomized placebo-controlled trial in long-term care facilities.

(2012/10) Cranberries for preventing urinary tract infections.

(2012/07) Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials.

(2011/06) Inhibition of adherence of multi-drug resistant E. coli by proanthocyanidin

(2011/01) Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial

(2009/07) Effects of cranberry juice on pharmacokinetics of beta-lactam antibiotics following oral administration

(2009/02) Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women

(2008/10) Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study.

(2007/06) Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells.

(2007/04) Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: a pilot double-blind placebo-controlled trial.

(2006/02) Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial.

(2005/11) Inhibition of uropathogenic Escherichia coli by cranberry juice: a new antiadherence assay.

(2005/09) A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity.

(2005/05) Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial.

(2002/06) A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women.

(2001/06) Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women.

(1998/10) Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries.






your cart
- + ×

Your cart is empty.


Free US Shipping

keep shopping Checkout

Net Orders Checkout

Item Price Qty Total
Subtotal $0.00

Shipping Address

Shipping Methods